Walmart Suspends Sale of Over the Counter Ranitidine Products
October 02 2019 - 9:22AM
Dow Jones News
By Michael Dabaie
Walmart Inc. (WMT) said it is suspending the sale of all over
the counter ranitidine products in stores, clubs and online,
including Zantac, Equate and Member's Mark brands.
The company said it is taking this action after closely
monitoring the recent product alert from the U.S. Food and Drug
Administration that ranitidine products may contain a low level of
nitrosodimethylamine, or NDMA.
NDMA is classified as a probable human carcinogen.
Customers who purchased these products may return them to
Walmart or Sam's Club for a refund, the retail company said.
CVS Health Corp. (CVS) said Saturday it suspended the sale of
all Zantac brand and CVS Health brand ranitidine products, citing
the FDA product alert.
Write to Michael Dabaie at michael.dabaie@wsj.com
(END) Dow Jones Newswires
October 02, 2019 09:07 ET (13:07 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Walmart (NYSE:WMT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Walmart (NYSE:WMT)
Historical Stock Chart
From Apr 2023 to Apr 2024
